Global Botulinum Toxin Type A Market Research Report 2023

Publication ID:

PB504234867

Publication Date:

April 21, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Agriculture [2]

Industry & Manufacturing [3]

Description:

Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
The global Botulinum Toxin Type A market was valued at US$ 6563.4 million in 2022 and is anticipated to reach US$ 8335.1 million by 2029, witnessing a CAGR of 3.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Botulinum Toxin Type A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botulinum Toxin Type A.
The Botulinum Toxin Type A market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Botulinum Toxin Type A market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botulinum Toxin Type A manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
Segment by Type
50 Units
100 Units
200 Units
Segment by Application
Cosmetic Applications
Therapeutic Applications
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Botulinum Toxin Type A manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Botulinum Toxin Type A by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Botulinum Toxin Type A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Botulinum Toxin Type A Market Overview
1.1 Product Definition
1.2 Botulinum Toxin Type A Segment by Type
1.2.1 Global Botulinum Toxin Type A Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 50 Units
1.2.3 100 Units
1.2.4 200 Units
1.3 Botulinum Toxin Type A Segment by Application
1.3.1 Global Botulinum Toxin Type A Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Cosmetic Applications
1.3.3 Therapeutic Applications
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Botulinum Toxin Type A Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Botulinum Toxin Type A Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Botulinum Toxin Type A Production Estimates and Forecasts (2018-2029)
1.4.4 Global Botulinum Toxin Type A Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Botulinum Toxin Type A Production Market Share by Manufacturers (2018-2023)
2.2 Global Botulinum Toxin Type A Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Botulinum Toxin Type A, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Botulinum Toxin Type A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Botulinum Toxin Type A Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Botulinum Toxin Type A, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Botulinum Toxin Type A, Product Offered and Application
2.8 Global Key Manufacturers of Botulinum Toxin Type A, Date of Enter into This Industry
2.9 Botulinum Toxin Type A Market Competitive Situation and Trends
2.9.1 Botulinum Toxin Type A Market Concentration Rate
2.9.2 Global 5 and 10 Largest Botulinum Toxin Type A Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Botulinum Toxin Type A Production by Region
3.1 Global Botulinum Toxin Type A Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Botulinum Toxin Type A Production Value by Region (2018-2029)
3.2.1 Global Botulinum Toxin Type A Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Botulinum Toxin Type A by Region (2024-2029)
3.3 Global Botulinum Toxin Type A Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Botulinum Toxin Type A Production by Region (2018-2029)
3.4.1 Global Botulinum Toxin Type A Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Botulinum Toxin Type A by Region (2024-2029)
3.5 Global Botulinum Toxin Type A Market Price Analysis by Region (2018-2023)
3.6 Global Botulinum Toxin Type A Production and Value, Year-over-Year Growth
3.6.1 North America Botulinum Toxin Type A Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Botulinum Toxin Type A Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Botulinum Toxin Type A Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Botulinum Toxin Type A Production Value Estimates and Forecasts (2018-2029)
4 Botulinum Toxin Type A Consumption by Region
4.1 Global Botulinum Toxin Type A Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Botulinum Toxin Type A Consumption by Region (2018-2029)
4.2.1 Global Botulinum Toxin Type A Consumption by Region (2018-2023)
4.2.2 Global Botulinum Toxin Type A Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Botulinum Toxin Type A Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Botulinum Toxin Type A Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Botulinum Toxin Type A Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Botulinum Toxin Type A Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Botulinum Toxin Type A Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Botulinum Toxin Type A Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Botulinum Toxin Type A Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Botulinum Toxin Type A Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Botulinum Toxin Type A Production by Type (2018-2029)
5.1.1 Global Botulinum Toxin Type A Production by Type (2018-2023)
5.1.2 Global Botulinum Toxin Type A Production by Type (2024-2029)
5.1.3 Global Botulinum Toxin Type A Production Market Share by Type (2018-2029)
5.2 Global Botulinum Toxin Type A Production Value by Type (2018-2029)
5.2.1 Global Botulinum Toxin Type A Production Value by Type (2018-2023)
5.2.2 Global Botulinum Toxin Type A Production Value by Type (2024-2029)
5.2.3 Global Botulinum Toxin Type A Production Value Market Share by Type (2018-2029)
5.3 Global Botulinum Toxin Type A Price by Type (2018-2029)
6 Segment by Application
6.1 Global Botulinum Toxin Type A Production by Application (2018-2029)
6.1.1 Global Botulinum Toxin Type A Production by Application (2018-2023)
6.1.2 Global Botulinum Toxin Type A Production by Application (2024-2029)
6.1.3 Global Botulinum Toxin Type A Production Market Share by Application (2018-2029)
6.2 Global Botulinum Toxin Type A Production Value by Application (2018-2029)
6.2.1 Global Botulinum Toxin Type A Production Value by Application (2018-2023)
6.2.2 Global Botulinum Toxin Type A Production Value by Application (2024-2029)
6.2.3 Global Botulinum Toxin Type A Production Value Market Share by Application (2018-2029)
6.3 Global Botulinum Toxin Type A Price by Application (2018-2029)
7 Key Companies Profiled
7.1 ALLERGAN
7.1.1 ALLERGAN Botulinum Toxin Type A Corporation Information
7.1.2 ALLERGAN Botulinum Toxin Type A Product Portfolio
7.1.3 ALLERGAN Botulinum Toxin Type A Production, Value, Price and Gross Margin (2018-2023)
7.1.4 ALLERGAN Main Business and Markets Served
7.1.5 ALLERGAN Recent Developments/Updates
7.2 Galderma
7.2.1 Galderma Botulinum Toxin Type A Corporation Information
7.2.2 Galderma Botulinum Toxin Type A Product Portfolio
7.2.3 Galderma Botulinum Toxin Type A Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Galderma Main Business and Markets Served
7.2.5 Galderma Recent Developments/Updates
7.3 Merz Pharma
7.3.1 Merz Pharma Botulinum Toxin Type A Corporation Information
7.3.2 Merz Pharma Botulinum Toxin Type A Product Portfolio
7.3.3 Merz Pharma Botulinum Toxin Type A Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Merz Pharma Main Business and Markets Served
7.3.5 Merz Pharma Recent Developments/Updates
7.4 DAEWOONG
7.4.1 DAEWOONG Botulinum Toxin Type A Corporation Information
7.4.2 DAEWOONG Botulinum Toxin Type A Product Portfolio
7.4.3 DAEWOONG Botulinum Toxin Type A Production, Value, Price and Gross Margin (2018-2023)
7.4.4 DAEWOONG Main Business and Markets Served
7.4.5 DAEWOONG Recent Developments/Updates
7.5 Ipsen
7.5.1 Ipsen Botulinum Toxin Type A Corporation Information
7.5.2 Ipsen Botulinum Toxin Type A Product Portfolio
7.5.3 Ipsen Botulinum Toxin Type A Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Ipsen Main Business and Markets Served
7.5.5 Ipsen Recent Developments/Updates
7.6 Pfizer
7.6.1 Pfizer Botulinum Toxin Type A Corporation Information
7.6.2 Pfizer Botulinum Toxin Type A Product Portfolio
7.6.3 Pfizer Botulinum Toxin Type A Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Pfizer Main Business and Markets Served
7.6.5 Pfizer Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Botulinum Toxin Type A Industry Chain Analysis
8.2 Botulinum Toxin Type A Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Botulinum Toxin Type A Production Mode & Process
8.4 Botulinum Toxin Type A Sales and Marketing
8.4.1 Botulinum Toxin Type A Sales Channels
8.4.2 Botulinum Toxin Type A Distributors
8.5 Botulinum Toxin Type A Customers
9 Botulinum Toxin Type A Market Dynamics
9.1 Botulinum Toxin Type A Industry Trends
9.2 Botulinum Toxin Type A Market Drivers
9.3 Botulinum Toxin Type A Market Challenges
9.4 Botulinum Toxin Type A Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂